C60衍生物通过调控Nrf2/NF-κB炎症平衡体系抑制小胶质细胞活化的研究

基本信息
批准号:31271071
项目类别:面上项目
资助金额:80.00
负责人:叶社房
学科分类:
依托单位:厦门大学
批准年份:2012
结题年份:2016
起止时间:2013-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:周樨,姜元芹,魏峰,张秀明,王东,张宏刚,周军,亢宁
关键词:
神经退行性变性Nrf2富勒烯NFκB小胶质细胞通路
结项摘要

Mounting evidence indicates that microglial activation contributes to neuronal damage in neurodegenerative disorders. Activated microglia can induce and release neurotoxic proinflammatory factors as well as reactive oxygen species (ROS), which lead to inflammation-mediated neuronal cell death.Therefore, control of microglial activation may alleviate the progression of neurodegeneration,suggesting that development of anti-inflammatory or antioxidant drugs could provide a potential therapeutic approach for neurodegenerative conditions.Research in the field of water-soluble C60 fullerene derivatives has significantly increased due to the broad range of biological activities found for these compounds.As the peculiar structure of C60 fullerenes not only serve as "radical sponge", but also may possess higher physical stability when in contact with biological fluids, show good biocompatibility in vivo and in vitro, and pass through the blood-brain barrier, the exceptional radical-scavenging property and biophysical properties of fullerene make them promising pharmacophore for development of drugs targeting neurodegenerative diseases. Although C60 fullerene derivatives have been reported to possess excellent neural protective efficacy in a broad spectrum of neurodisorders, the effect of C60 fullerene derivatives on microglial activation remains to be elucidated.The research proposed here will be undertaken to investigate the effects of C60 fullerene derivatives (C60-OH,C60-COOH)on LPS-induced inflammatory responses using a microglial cell line in vitro and animal models of LPS-induced inflammation in mouse hippocampus. We will elucidate the cellular and molecular mechanisms underlying anti-inflammatory activity of C60 nanoparticles, focusing on whether C60 fullerene derivatives activate antioxidant defense via the Nrf2 pathway and inhibit inflammation via NF-κB inhibition, and whether C60 nanoparticles-induced activation of Nrf2 signaling could be a major cellular mechanism mediating anti-inflammatory effect of C60 nanoparticles. This proposal will provide mechanistic insights into the therapeutic potential of C60 nanoparticles in neuronal cell damage induced by activated microglia, and open the possibility of developing fullerene derivatives with potent biomedical applications in neurodegenerative disorders.

脑神经退行性病变是严重危害人类健康的神经系统疾病,目前尚无理想防治药物。小胶质细胞活化介导的炎性神经变性损伤是多种脑神经退行性病变的主要致病机制,因此抑制小胶质细胞活化是防治这类疾病的重要干预策略之一。水溶性富勒烯C60衍生物特殊的理化性能赋予其多重独特的生物学活性,使其在神经退行性病变防治中显示出潜在的应用前景。然而,C60衍生物对小胶质细胞活化行为的影响及机制尚不清楚。本项目通过脂多糖(LPS)活化的小胶质细胞为体外模型,结合小胶质细胞活化介导的脑神经损伤体内模型,从分子、细胞及动物整体多层次、纵深探讨羟基或羧基化C60衍生物对活化小胶质细胞诱导的氧化应激及炎症反应的影响,阐明其对Nrf2/NF-κB炎症平衡体系的调控作用,以期揭示羟基或羧基化C60衍生物抑制活化小胶质细胞介导的神经组织变性的新机制。研究有望为脑神经退变性疾病的防治以及新型神经保护药物的开发提供科学依据。

项目摘要

本研究以细菌内毒素脂多糖、人源朊蛋白多肽等诱导建立了小胶质细胞活化及细胞氧化应激损伤模型,阐明了不同功能基团(如羟基、羧基及氨基)修饰的代表性水溶性富勒烯衍生物对小胶质细胞活化介导的脑神经组织炎性损伤的多靶点协同保护机制。研究发现,富勒烯衍生物通过调控线粒体动力、线粒体膜电位、氧化应激状态、抗氧化酶及MAPK信号途径多靶点机制,抑制小胶质细胞活化及其介导的炎性神经元细胞损伤;利用RNA干扰技术建立Nrf2基因缺陷细胞模型,证实了富勒烯衍生物是通过活化Nrf2/HO-1抗氧化系统,抑制NF-kB炎症途径作为细胞对抗小胶质细胞活化及细胞氧化应激损伤的重要机制,这一机制在过氧化氢诱导的体外细胞模型中得到了进一步证实。经脑内注射细菌内毒素脂多糖建立脑神经炎症损伤模型,通过对脑功能行为学评价、病理学观察、炎症诱导蛋白酶、及抗氧化抗炎蛋白酶的检测等,进一步明确了富勒烯衍生物对脑神经炎症性损伤的保护作用。总之,通过该项目研究为拓展功能化富勒烯衍生物在脑神经系统退行性炎症性疾病的治疗与预防中的应用提供科学理论依据,对促进新型神经保护药物的开发提供新的策略与思路。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

小跨高比钢板- 混凝土组合连梁抗剪承载力计算方法研究

小跨高比钢板- 混凝土组合连梁抗剪承载力计算方法研究

DOI:10.19701/j.jzjg.2015.15.012
发表时间:2015
2

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021
3

视网膜母细胞瘤的治疗研究进展

视网膜母细胞瘤的治疗研究进展

DOI:
发表时间:2018
4

Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia

Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia

DOI:10.1016/j.fitote.2020.104491
发表时间:2020
5

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

DOI:
发表时间:2021

叶社房的其他基金

批准号:30901175
批准年份:2009
资助金额:22.00
项目类别:青年科学基金项目

相似国自然基金

1

人参皂苷Rh2抑制胶质瘤相关小胶质细胞/巨噬细胞中NF-κB活化对胶质瘤治疗作用的机制研究

批准号:81573460
批准年份:2015
负责人:李少一
学科分类:H3505
资助金额:50.00
项目类别:面上项目
2

基于NLRP3炎症小体探讨NF-κB通过调控小胶质细胞极化影响阿尔茨海默病变的分子机理研究

批准号:81873812
批准年份:2018
负责人:郑翔宇
学科分类:H1902
资助金额:61.00
项目类别:面上项目
3

黄芩苷抑制Aβ诱导小胶质细胞活化和炎症反应的作用及机制研究

批准号:81041026
批准年份:2010
负责人:耿淼
学科分类:H0907
资助金额:10.00
项目类别:专项基金项目
4

萝卜硫素抑制NF-κB信号通路调控小胶质细胞与星形胶质细胞突触修剪功能治疗ASD的作用及机制研究

批准号:81873806
批准年份:2018
负责人:李亚敏
学科分类:H1008
资助金额:56.00
项目类别:面上项目